J. Veselka, N. Anavekar, and P. Charron, Hypertrophic obstructive cardiomyopathy. The Lancet, 2016.

K. Mcdonald, E. Mcwilliams, O. Keefe, B. Maurer, and B. , Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy, European Heart Journal, vol.9, issue.8, pp.893-898, 1988.
DOI : 10.1093/oxfordjournals.eurheartj.a062584

X. Jeanrenaud and J. Goy, Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy, The Lancet, vol.339, issue.8805, pp.1318-1323, 1992.
DOI : 10.1016/0140-6736(92)91961-7

L. Fananapazir, R. Cannon, D. Tripodi, and J. Panza, Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy, Circulation, vol.85, issue.6, pp.2149-2161, 1992.
DOI : 10.1161/01.CIR.85.6.2149

L. Fananapazir, N. Epstein, R. Curiel, J. Panza, D. Tripodi et al., Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy, Circulation, vol.90, issue.6, pp.2731-2742, 1994.
DOI : 10.1161/01.CIR.90.6.2731

A. Slade, N. Sadoul, L. Shapiro, L. Chojnowska, J. Simon et al., DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience., Heart, vol.75, issue.1, pp.44-49, 1996.
DOI : 10.1136/hrt.75.1.44

R. Nishimura, J. Trusty, D. Hayes, D. Ilstrup, D. Larson et al., Dual-Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double-Blind, Crossover Trial, Journal of the American College of Cardiology, vol.29, issue.2, pp.435-441, 1997.
DOI : 10.1016/S0735-1097(96)00473-1

L. Kappenberger, C. Linde, C. Daubert, W. Mckenna, E. Meisel et al., Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study, European Heart Journal, vol.18, issue.8, 1997.
DOI : 10.1093/oxfordjournals.eurheartj.a015435